1. Home
  2. GHRS vs FIGS Comparison

GHRS vs FIGS Comparison

Compare GHRS & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • FIGS
  • Stock Information
  • Founded
  • GHRS 2018
  • FIGS 2013
  • Country
  • GHRS Ireland
  • FIGS United States
  • Employees
  • GHRS N/A
  • FIGS N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • FIGS Apparel
  • Sector
  • GHRS Health Care
  • FIGS Consumer Discretionary
  • Exchange
  • GHRS Nasdaq
  • FIGS Nasdaq
  • Market Cap
  • GHRS 583.1M
  • FIGS 694.0M
  • IPO Year
  • GHRS 2021
  • FIGS 2021
  • Fundamental
  • Price
  • GHRS $10.60
  • FIGS $4.95
  • Analyst Decision
  • GHRS Strong Buy
  • FIGS Hold
  • Analyst Count
  • GHRS 8
  • FIGS 5
  • Target Price
  • GHRS $30.63
  • FIGS $4.75
  • AVG Volume (30 Days)
  • GHRS 146.4K
  • FIGS 1.6M
  • Earning Date
  • GHRS 05-08-2025
  • FIGS 05-08-2025
  • Dividend Yield
  • GHRS N/A
  • FIGS N/A
  • EPS Growth
  • GHRS N/A
  • FIGS N/A
  • EPS
  • GHRS N/A
  • FIGS 0.01
  • Revenue
  • GHRS N/A
  • FIGS $561,166,000.00
  • Revenue This Year
  • GHRS N/A
  • FIGS $0.34
  • Revenue Next Year
  • GHRS N/A
  • FIGS $3.94
  • P/E Ratio
  • GHRS N/A
  • FIGS $700.24
  • Revenue Growth
  • GHRS N/A
  • FIGS 3.02
  • 52 Week Low
  • GHRS $6.00
  • FIGS $3.57
  • 52 Week High
  • GHRS $20.50
  • FIGS $7.06
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 59.36
  • FIGS 65.09
  • Support Level
  • GHRS $9.81
  • FIGS $4.41
  • Resistance Level
  • GHRS $11.50
  • FIGS $4.08
  • Average True Range (ATR)
  • GHRS 0.72
  • FIGS 0.25
  • MACD
  • GHRS 0.23
  • FIGS 0.14
  • Stochastic Oscillator
  • GHRS 89.60
  • FIGS 86.45

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

Share on Social Networks: